Welcome to our dedicated page for Chemours news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours stock.
The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.
Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.
Chemours (NYSE: CC) announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B) refrigerants for stationary chiller applications serving AI-driven data centers, commercial buildings, and other mission-critical environments. The additions expand the low-global warming potential (GWP) Opteon™ portfolio targeting high-growth cooling markets.
Opteon™ ZE is an HFO refrigerant with an ultra-low GWP of approximately 1 (AR5), zero ozone depletion potential (ODP), ASHRAE A2L (mildly flammable) classification, and is suited for air- and water-cooled chillers, commercial AC, heat pumps, and data center cooling. Opteon™ 515B is a zero-ODP blend of about 91.1% R-1234ze(E) and 8.9% R-227ea, with GWP around 293 (AR4) and ASHRAE A1 (no flame propagation) classification, aimed at customers transitioning from higher-GWP refrigerants. Chemours highlights its fluorochemicals expertise, IP portfolio, and plans to provide dependable long-term supply. Both products are available now in strategic countries, with broader rollout expected based on demand.
Chemours (NYSE: CC) announced that its Board of Directors has declared a third-quarter 2026 quarterly cash dividend of $0.0875 per share on its common stock. The dividend is scheduled to be paid on September 15, 2026 to shareholders of record as of August 14, 2026.
The Chemours Company (NYSE: CC) reported Q2 2026 Net Sales of $1.59 billion, down 1% year-over-year, with a 4% volume decline partly offset by 2% higher pricing and a 1% currency benefit. Net loss attributable to Chemours narrowed to $274 million (‑$1.81 per diluted share) from a $380 million loss, reflecting legal and environmental reserves tied to settlements and ongoing litigation, partially offset by a gain on the Kuan Yin property sale.
Adjusted Net Income was $64 million ($0.42 per share) and Adjusted EBITDA was $247 million, down 5% year-over-year but up 46% sequentially. Free Cash Flow rose to $114 million, a 128% increase, with Free Cash Flow Conversion of 46% and net leverage reduced to 4.4x. TSS delivered $213 million Adjusted EBITDA (+3%), TT benefited from about 5% year‑to‑date TiO2 price increases, and APM’s Performance Solutions Net Sales grew 8% year-over-year. Chemours paid down €230 million of term loan debt and, for full-year 2026, continues to expect Net Sales growth of 1%–5% and Adjusted EBITDA of $775–$825 million, with Free Cash Flow Conversion above 25% and year-end net leverage around 3.8x.
Chemours (NYSE: CC) announced it will release its second quarter 2026 financial results after market close on Tuesday, August 4, 2026. Management will host a public webcast conference call to discuss the results at 8:00 a.m. EDT on Wednesday, August 5, 2026.
According to Chemours, investors can access the live webcast, accompanying slides, and related materials through the “Events and Presentations” section of the Investor Relations page at investors.chemours.com. A replay of the webcast will also be available on the same site after the event.
Chemours (NYSE: CC) announced a settlement with the U.S. EPA and West Virginia regulators to resolve claims related to PFAS discharges at three operating sites. The company will pay a $22.5 million civil penalty over three years and fund $90 million in mitigation projects over 15 years.
The agreement includes expanded off-site drinking water programs that are expected to increase environmental reserves and is documented in a proposed Consent Decree subject to court approval. Chemours also resolved related litigation with the West Virginia Rivers Coalition for less than $1 million.
Chemours (NYSE: CC) declared a quarterly cash dividend of $0.0875 per share for the second quarter of 2026. The dividend is payable on June 16, 2026 to shareholders of record as of the close of business on May 17, 2026.
Chemours (NYSE: CC) reported Q1 2026 results: Net Sales $1.38B, Net Loss attributable to Chemours of $29M (loss per diluted share $0.19), and Adjusted EBITDA $169M. TSS delivered record quarterly sales and margins; TT and APM saw lower volumes and margin contraction. The company received ~$287M net proceeds from Kuan Yin land sales and used funds to pay down €140M of debt; total liquidity was $1.5B and net leverage ~4.9x. Q2 guidance: consolidated Adjusted EBITDA $220M–$250M; full-year Adjusted EBITDA $800M–$900M.
Chemours (NYSE: CC) expects to release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026, and will host a public webcast conference call at 8:00 a.m. Eastern Time on Wednesday, May 6, 2026.
The live webcast, accompanying slides and a replay will be available in the Events and Presentations section of Chemours' Investor Relations website at investors.chemours.com.
The Chemours Company (NYSE: CC) completed a private offering of $700,000,000 aggregate principal amount of 7.875% senior unsecured notes due 2034 on March 12, 2026.
Chemours used net proceeds plus cash on hand to redeem $188,000,000 of 5.750% notes due 2028 and expects to use remaining proceeds to redeem outstanding 5.375% notes due 2027 for an aggregate redemption price of approximately $500,300,000 (assuming a 3.56% treasury rate), plus accrued interest.
Chemours (NYSE: CC) priced an upsized private offering of $700,000,000 aggregate principal amount of 7.875% senior notes due March 15, 2034, up from a previously announced $600,000,000.
Interest will be paid semi‑annually starting September 15, 2026; closing is expected March 12, 2026. Net proceeds are intended to fund redemptions of the company's 5.375% senior notes due 2027 and a partial redemption of its 5.750% senior notes due 2028.